Founded in 2018, BriSTAR Immunotech (Beijing)Biotechnology Co., LTD is dedicated to biopharmaceutics research and development. The company focuses on developing and commercializing the products of cellular immunotherapy for cancer and other diseases. The STAR-T and enTCR-T are the two unique core technological platforms that they have developed.